pharma
How is COVID-19 impacting the rare disease community?
June 22, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease
The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …
Sanofi’s Dupixent scores Chinese approval in moderate to severe atopic dermatitis
June 22, 2020Sales and Marketing China, Dupixent, Sanofi, atopic dermatitis, pharma
China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent …
New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market
June 22, 2020Manufacturing and Production, Sales and Marketing COVID-19, DSRU, MEMO Research, Vaccine, coronavirus, pharma
The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together …
Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2
June 16, 2020Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …
COVID-19: UK and Europe life sciences regulatory developments
June 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation
Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million
June 12, 2020Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale
Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …
MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer
June 11, 2020Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure
MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …
AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn
June 11, 2020Research and Development AbbVie, Genmab, partnership, pharma
AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …
How digital therapeutics are revolutionising healthcare
June 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma
Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents
June 10, 2020Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma
Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
Lundbeck to restructure R&D, shedding up to 160 jobs
June 10, 2020Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …
Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1
June 9, 2020Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease
Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …
AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients
June 8, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma
AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
Oxford Biomedica joins forces with UK’s Vaccines Manufacturing and Innovation Centre to scale up production of Oxford Uni’s COVID-19 vaccine
June 8, 2020Manufacturing and Production, Sales and Marketing COVID-19, Oxford BioMedica, University of Oxford, Vaccine, coronavirus, pharma
Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …
Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma
June 2, 2020Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma
Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
